1300 856 695
+44 203 514 0688
1800 867 1390If you would like to submit a blog post for consideration, please email admin@healthcert.com
Research Review on Dermatology [January]
The January research review on dermatology discusses preliminary research evaluating genetically corrected autologous epidermal grafts for treating recessive dystrophic epidermolysis bullosa. Two papers focus on infantile haemangioma, one describing sequelae and their risk factors following regression, and the other reporting superiority of topical timolol over ultrapotent corticosteroids for their treatment. Data from US population-based surveys confirmed that AD is associated with ADD/ADHD in adults as well as children.
Featured in this issue:
- Coronary artery calcium in psoriasis and type 2 diabetes
- Effect of ixekizumab on psoriasis itch severity
- Ixekizumab for scalp psoriasis
- HLA-Cw6 homozygosity and strep throat in plaque psoriasis
- Coronary artery disease progression and biologic agents
- Psoriasis and obstructive sleep apnea
- Vasoconstriction with calcipotriol plus betamethasone dipropionate
- Long-term clinical safety and efficacy of brodalumab
- Psoriasis itch VAS for psoriasis vulgaris
- DLQI as a criterion for systemic agents
Click here to download the full paper
Interested in General Dermatology?
The HealthCert Professional Diploma of General Dermatology will teach you how to manage all major dermatological conditions in primary care. The courses are university quality-assured, CPD-accredited and count towards multiple Master degree pathways and clinical attachment programs in Australia and overseas. The program is delivered online.
1300 856 695
+44 203 514 0688
1800 867 1390
